The Hidden Dangers of SSRIs During Pregnancy

Researchers have long been puzzled about the safety of selective serotonin reuptake inhibitors, or SSRIs, during pregnancy. A major challenge in studying this issue is the ethics of conducting randomized trials. Without a clear understanding of the risks, pregnant women and their doctors are left making tough decisions. A recent study took a closer look at what happens when women continue or stop taking SSRIs during pregnancy.

The study analyzed data from over 1,000 pregnancies and found some surprising results. Babies born to mothers who continued taking SSRIs during pregnancy had lower Apgar scores, a measure of their overall health. Specifically, the Apgar scores at 1 minute and 5 minutes were lower by 0.39 and 0.28 points, respectively. These babies were also more likely to have meconium in their amniotic fluid, which can be a sign of stress.

However, the study didn't find any significant differences in more serious complications, such as admission to the neonatal intensive care unit. The rate of congenital anomalies was also similar between the two groups, although the study notes that this finding should be interpreted with caution due to the limited sample size. Other outcomes, such as preterm birth, birth weight, and respiratory distress, were also similar.

The study's findings suggest that continuing SSRIs during pregnancy may lead to some short-term health issues for newborns. But it's essential to consider these risks in the context of the potential benefits of taking SSRIs. For some women, the benefits of these medications may outweigh the risks. The study highlights the importance of careful decision-making and close monitoring during pregnancy.

The researchers used a unique approach called target trial emulation to minimize bias in their study. This approach allowed them to compare the outcomes of pregnancies where the mother continued taking SSRIs with those where she stopped. By doing so, they were able to get a clearer picture of the potential risks and benefits of SSRIs during pregnancy. Their work emphasizes the need for more research into the safety of medications during pregnancy.